Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.890
-0.370 (-8.69%)
Mar 16, 2026, 11:35 AM EDT - Market open
Evaxion Market Cap
Evaxion has a market cap or net worth of $162.22 million as of March 16, 2026. Its market cap has increased by 1,132.67% in one year.
Market Cap
162.22M
Enterprise Value
161.92M
1-Year Change
1,132.67%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $162.22M, a decrease of -15.51%. That is a compound annual growth rate of -3.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 35.53M | -10.69% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 37.96M |
| Xilio Therapeutics | 37.62M |
| Celularity | 35.46M |
| Tvardi Therapeutics | 35.09M |
| PDS Biotechnology | 34.99M |
| INmune Bio | 34.69M |
| Actinium Pharmaceuticals | 34.63M |
| Pluri | 34.57M |